Development of an intervention to facilitate implementation and uptake of diabetic retinopathy screening.
Diabetic Retinopathy
/ diagnosis
Health Education
/ organization & administration
Health Personnel
/ education
Humans
Implementation Science
Mass Screening
/ organization & administration
Patient Education as Topic
Patients
Primary Health Care
/ organization & administration
Psychological Theory
Quality Improvement
/ organization & administration
Family Practitioner
Implementation Intervention
Intervention development
Patient and Public Involvement (PPI)
Retinal Screening
Stakeholder consultation
Theoretical Domains Framework
Journal
Implementation science : IS
ISSN: 1748-5908
Titre abrégé: Implement Sci
Pays: England
ID NLM: 101258411
Informations de publication
Date de publication:
19 05 2020
19 05 2020
Historique:
received:
14
10
2019
accepted:
12
03
2020
entrez:
21
5
2020
pubmed:
21
5
2020
medline:
25
5
2021
Statut:
epublish
Résumé
'Implementation interventions' refer to methods used to enhance the adoption and implementation of clinical interventions such as diabetic retinopathy screening (DRS). DRS is effective, yet uptake is often suboptimal. Despite most routine management taking place in primary care and the central role of health care professionals (HCP) in referring to DRS, few interventions have been developed for primary care. We aimed to develop a multifaceted intervention targeting both professionals and patients to improve DRS uptake as an example of a systematic development process combining theory, stakeholder involvement, and evidence. First, we identified target behaviours through an audit in primary care of screening attendance. Second, we interviewed patients (n = 47) and HCP (n = 30), to identify determinants of uptake using the Theoretical Domains Framework, mapping these to behaviour change techniques (BCTs) to develop intervention content. Thirdly, we conducted semi-structured consensus groups with stakeholders, specifically users of the intervention, i.e. patients (n = 15) and HCPs (n = 16), regarding the feasibility, acceptability, and local relevance of selected BCTs and potential delivery modes. We consulted representatives from the national DRS programme to check intervention 'fit' with existing processes. We applied the APEASE criteria (affordability, practicability, effectiveness, acceptability, side effects, and equity) to select the final intervention components, drawing on findings from the previous steps, and a rapid evidence review of operationalised BCT effectiveness. We identified potentially modifiable target behaviours at the patient (consent, attendance) and professional (registration) level. Patient barriers to consent/attendance included confusion between screening and routine eye checks, and fear of a negative result. Enablers included a recommendation from friends/family or professionals and recognising screening importance. Professional barriers to registration included the time to register patients and a lack of readily available information on uptake in their local area/practice. Most operationalised BCTs were acceptable to patients and HCPs while the response to feasibility varied. After considering APEASE, the core intervention, incorporating a range of BCTs, involved audit/feedback, electronic prompts targeting professionals, HCP-endorsed reminders (face-to-face, by phone and letter), and an information leaflet for patients. Using the example of an intervention to improve DRS uptake, this study illustrates an approach to integrate theory with user involvement. This process highlighted tensions between theory-informed and stakeholder suggestions, and the need to apply the Theoretical Domains Framework (TDF)/BCT structure flexibly. The final intervention draws on the trusted professional-patient relationship, leveraging existing services to enhance implementation of the DRS programme. Intervention feasibility in primary care will be evaluated in a randomised cluster pilot trial.
Sections du résumé
BACKGROUND
'Implementation interventions' refer to methods used to enhance the adoption and implementation of clinical interventions such as diabetic retinopathy screening (DRS). DRS is effective, yet uptake is often suboptimal. Despite most routine management taking place in primary care and the central role of health care professionals (HCP) in referring to DRS, few interventions have been developed for primary care. We aimed to develop a multifaceted intervention targeting both professionals and patients to improve DRS uptake as an example of a systematic development process combining theory, stakeholder involvement, and evidence.
METHODS
First, we identified target behaviours through an audit in primary care of screening attendance. Second, we interviewed patients (n = 47) and HCP (n = 30), to identify determinants of uptake using the Theoretical Domains Framework, mapping these to behaviour change techniques (BCTs) to develop intervention content. Thirdly, we conducted semi-structured consensus groups with stakeholders, specifically users of the intervention, i.e. patients (n = 15) and HCPs (n = 16), regarding the feasibility, acceptability, and local relevance of selected BCTs and potential delivery modes. We consulted representatives from the national DRS programme to check intervention 'fit' with existing processes. We applied the APEASE criteria (affordability, practicability, effectiveness, acceptability, side effects, and equity) to select the final intervention components, drawing on findings from the previous steps, and a rapid evidence review of operationalised BCT effectiveness.
RESULTS
We identified potentially modifiable target behaviours at the patient (consent, attendance) and professional (registration) level. Patient barriers to consent/attendance included confusion between screening and routine eye checks, and fear of a negative result. Enablers included a recommendation from friends/family or professionals and recognising screening importance. Professional barriers to registration included the time to register patients and a lack of readily available information on uptake in their local area/practice. Most operationalised BCTs were acceptable to patients and HCPs while the response to feasibility varied. After considering APEASE, the core intervention, incorporating a range of BCTs, involved audit/feedback, electronic prompts targeting professionals, HCP-endorsed reminders (face-to-face, by phone and letter), and an information leaflet for patients.
CONCLUSIONS
Using the example of an intervention to improve DRS uptake, this study illustrates an approach to integrate theory with user involvement. This process highlighted tensions between theory-informed and stakeholder suggestions, and the need to apply the Theoretical Domains Framework (TDF)/BCT structure flexibly. The final intervention draws on the trusted professional-patient relationship, leveraging existing services to enhance implementation of the DRS programme. Intervention feasibility in primary care will be evaluated in a randomised cluster pilot trial.
Identifiants
pubmed: 32429983
doi: 10.1186/s13012-020-00982-4
pii: 10.1186/s13012-020-00982-4
pmc: PMC7236930
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
34Commentaires et corrections
Type : ErratumIn
Références
Cancer Causes Control. 2006 Feb;17(1):45-52
pubmed: 16411052
J Med Screen. 2017 Sep;24(3):127-145
pubmed: 27754937
J Gen Intern Med. 2002 Jul;17(7):521-30
pubmed: 12133142
Diabet Med. 2018 Oct;35(10):1308-1319
pubmed: 29790594
PLoS One. 2019 Oct 15;14(10):e0223615
pubmed: 31613913
Cochrane Database Syst Rev. 2015 Apr 29;(4):CD005470
pubmed: 25923419
Syst Rev. 2016 Aug 11;5(1):134
pubmed: 27515938
Health Psychol. 2003 Jan;22(1):99-105
pubmed: 12558207
Am J Ophthalmol. 2018 Oct;194:54-62
pubmed: 30053472
Implement Sci. 2017 May 12;12(1):62
pubmed: 28499408
Arch Ophthalmol. 2011 Dec;129(12):1592-8
pubmed: 22159679
Diabetes Res Clin Pract. 2012 Apr;96(1):10-6
pubmed: 22137363
Curr Diab Rep. 2018 May 24;18(7):41
pubmed: 29797076
J Healthc Qual. 1999 Nov-Dec;21(6):35-8, 46
pubmed: 10662085
BMJ Open. 2019 May 30;9(5):e028756
pubmed: 31152042
Diabetes Res Clin Pract. 2011 Jul;93(1):1-9
pubmed: 21382643
Implement Sci. 2017 Aug 29;12(1):108
pubmed: 28851459
J Psychol. 1975 Sep;91(1):93-114
pubmed: 28136248
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Implement Sci. 2016 Feb 03;11:14
pubmed: 26841877
Diabetes Metab Syndr. 2012 Oct-Dec;6(4):199-202
pubmed: 23199538
Eye (Lond). 2012 May;26(5):671-7
pubmed: 22302063
Am J Med Qual. 2016 Mar-Apr;31(2):156-61
pubmed: 25270737
Diabetes Care. 2019 Mar;42(3):427-433
pubmed: 30679304
Can J Ophthalmol. 2015 Apr;50(2):119-26
pubmed: 25863851
Implement Sci. 2014 Aug 06;9:87
pubmed: 25098587
Implement Sci. 2015 May 25;10:74
pubmed: 26003785
Surv Ophthalmol. 2012 Jul-Aug;57(4):347-70
pubmed: 22542913
J Epidemiol Community Health. 1997 Apr;51(2):187-91
pubmed: 9196650
Health Expect. 2020 Aug;23(4):870-883
pubmed: 32356592
Diabet Med. 2010 Mar;27(3):249-56
pubmed: 20536486
PLoS One. 2013 Jun 13;8(6):e65471
pubmed: 23785427
Front Public Health. 2019 Jan 22;7:3
pubmed: 30723713
BMC Med Res Methodol. 2016 Aug 26;16(1):110
pubmed: 27566679
Br J Health Psychol. 2019 May;24(2):334-356
pubmed: 30793445
Soc Sci Med. 2014 Mar;104:31-40
pubmed: 24581059
Ophthalmic Epidemiol. 2000 Sep;7(3):209-18
pubmed: 11035555
Res Involv Engagem. 2019 Jan 9;5:2
pubmed: 30652027
Diabetes Care. 2017 Jan;40(Suppl 1):S128-S129
pubmed: 27979902
Pilot Feasibility Stud. 2019 Mar 12;5:41
pubmed: 30923626
Implement Sci. 2013 Dec 01;8:139
pubmed: 24289295
Diabetes Care. 1997 Apr;20(4):520-3
pubmed: 9096973
Diabetes Care. 1999 May;22(5):752-5
pubmed: 10332676
Diab Vasc Dis Res. 2014 May 19;11(4):294-297
pubmed: 24845073
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Diabetes Educ. 2019 Apr;45(2):214-224
pubmed: 30739546
Health Educ Q. 1988 Summer;15(2):175-83
pubmed: 3378902
Diabet Med. 1998 Nov;15 Suppl 3:S14-24
pubmed: 9829764
Diabet Med. 1998 Nov;15 Suppl 3:S38-43
pubmed: 9829768
Adm Policy Ment Health. 2011 Jan;38(1):4-23
pubmed: 21197565
Diabet Med. 2016 Apr;33(4):441-5
pubmed: 26112979
Implement Sci. 2017 Jan 5;12(1):2
pubmed: 28057049
BMC Cancer. 2015 Mar 21;15:162
pubmed: 25884168
BMC Ophthalmol. 2008 May 31;8:9
pubmed: 18513438
Implement Sci. 2016 Jul 28;11:107
pubmed: 27464711
Implement Sci. 2012 Apr 24;7:38
pubmed: 22531013
Am J Public Health. 1999 Dec;89(12):1878-82
pubmed: 10589324
HRB Open Res. 2019 Jul 26;2:17
pubmed: 32104778
Am J Prev Med. 2007 Oct;33(4):318-35
pubmed: 17888859
Diabet Med. 2010 Mar;27(3):282-8
pubmed: 20536490
Implement Sci. 2008 Mar 19;3:17
pubmed: 18353186
Retina. 2008 Feb;28(2):195-200
pubmed: 18301023
Health Technol Assess. 2018 May;22(29):1-160
pubmed: 29855423
Br J Gen Pract. 2016 Feb;66(643):e114-27
pubmed: 26823263
JAMA Ophthalmol. 2015 Sep;133(9):1005-12
pubmed: 26068230
Ophthalmology. 2006 Aug;113(8):1372-7
pubmed: 16769120
Trials. 2017 Dec 19;18(1):602
pubmed: 29258565
Br J Ophthalmol. 2006 Mar;90(3):367-71
pubmed: 16488964
Ethn Dis. 2003 Winter;13(1):40-6
pubmed: 12723011
Am J Manag Care. 2010 Dec;16(12 Suppl HIT):SP72-81
pubmed: 21314226
Diabetes Care. 2012 Mar;35(3):556-64
pubmed: 22301125
Qual Saf Health Care. 2005 Feb;14(1):26-33
pubmed: 15692000
J Health Care Poor Underserved. 2014 Nov;25(4):1552-70
pubmed: 25418227
Diabetes Care. 2004 Jan;27 Suppl 1:S84-7
pubmed: 14693935
Ophthalmology. 2003 Sep;110(9):1683-9
pubmed: 13129862
PLoS One. 2018 Nov 2;13(11):e0206742
pubmed: 30388172
Br J Health Psychol. 2015 Feb;20(1):130-50
pubmed: 24815766
Diabetes Res Clin Pract. 2017 Jul;129:16-24
pubmed: 28499163
Implement Sci. 2016 Mar 22;11:40
pubmed: 27001107
Lancet. 2012 Jun 16;379(9833):2252-61
pubmed: 22683130
Lancet. 2003 Oct 11;362(9391):1225-30
pubmed: 14568747
J Med Screen. 2008;15(1):1-4
pubmed: 18416946
Cochrane Database Syst Rev. 2018 Jan 15;1:CD012054
pubmed: 29333660
Health Psychol. 2014 May;33(5):465-74
pubmed: 23730717
BMJ. 2000 Aug 12;321(7258):405-12
pubmed: 10938048
Lancet Public Health. 2017 Dec;2(12):e551-e559
pubmed: 29253440
J Natl Cancer Inst Monogr. 2012 May;2012(44):34-41
pubmed: 22623594
J Behav Health Serv Res. 2017 Apr;44(2):177-194
pubmed: 26289563
Am J Med Qual. 2000 Nov-Dec;15(6):257-62
pubmed: 11126595
J Med Screen. 2006;13(3):152-5
pubmed: 17007657
Implement Sci. 2018 Nov 22;13(1):143
pubmed: 30466450
Psychol Bull. 1982 Jul;92(1):111-35
pubmed: 7134324
Lancet. 2010 Jul 10;376(9735):124-36
pubmed: 20580421